Hydralazine Hydrochloride Tablets Recalled Due to Impurities and Degradation
SKY Packaging recalls Hydralazine Hydrochloride 25 mg tablets nationwide due to failed quality specifications for impurities and degradation.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of prescription drug due to failed quality specifications for impurities and degradation. No illnesses or injuries reported. Quality specification failures represent risk-of-harm products, meeting the High severity criterion.
Plain-English summary
SKY Packaging is recalling specific lots of Hydralazine Hydrochloride 25 mg tablets. The affected product was manufactured by Strides Pharma Science Ltd in Bengaluru, India, and distributed nationwide in the United States. The affected lot numbers are 0000127312 (expiration date March 31, 2025), 0000127576 (expiration date July 31, 2025), 0000127577 (expiration date July 31, 2025), 0000128204 (expiration date December 31, 2025), and 0000128358 (expiration date January 31, 2026).
The recall was initiated because the tablets failed quality specifications for impurities and degradation. Hydralazine Hydrochloride is a prescription medication. The FDA classified this as a Class II recall.
Patients or anyone who may have received one of the affected lots should contact their pharmacy or healthcare provider to confirm whether they received the recalled medication. Healthcare providers and patients should discuss what steps to take, as patients should not discontinue their medication without medical guidance.
The recalled product
- Product
- HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10
- Manufacturer
- SKY PACKAGING
- Category
- Drug
- Hazard
- impurities
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: 0000127312
- Exp. Date 31-Mar-2025
- 0000127576
- 0000127577
- Exp. Date 31-Jul-2025
- 0000128204
- Exp. Date 31-Dec-2025
- 0000128358
- Exp. Date 31-Jan-2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27